/ Not yet recruitingPhase 1/2IIT A PHASE II, SINGLE-CENTER, RANDOMIZED DOUBLE BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFECT OF THE COMBINED THERAPY OF EH-301 AND N-ACETYLCYSTEINE TOGETHER WITH RILUZOLE IN AMBULANT PATIENTS DIAGNOSED WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS) - NADALS-001-ALS -2021
/ Not yet recruitingPhase 3IIT Efficacy of subcutaneous butylscopolamine vs placebo for control to death rattle in agony. Randomized clinical trial. - the ECABUSCA12 trial
/ Not yet recruitingPhase 2IIT Gabapentin int he disorder of the impulse control in the Parkinson´s Disease: multicentric study, double-blind, randomized, controlled with placebo. - IMULPARK
100 Clinical Results associated with Asociacion Instituto Biodonostia
0 Patents (Medical) associated with Asociacion Instituto Biodonostia
100 Deals associated with Asociacion Instituto Biodonostia
100 Translational Medicine associated with Asociacion Instituto Biodonostia